Phase II Trial of Everolimus or Everolimus plus Paclitaxel as First-line Therapy in Cisplatin-ineligible participants with Advanced Urothelial Carcinoma: Hoosier Oncology Group GU10-147

  • Jana, Bagi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date8/23/138/22/19

    Funding

    • Hoosier Cancer Research Network: $5,965.85